Amicus Effort Backs Tech and Life Sciences Innovators in U.S. Supreme Court Case

1 minute read | June.25.2024

  • In a case of importance to the tech and life science sectors, an Orrick team has filed an amicus brief urging the U.S. Supreme Court to take up and reverse a Federal Circuit decision with broad ramifications for the patent system.
  • The brief was filed in In re Cellect on behalf of Sonos, RingCentral, NAGRA Kudeleski Group and Capstan Therapeutics. The broad cross-section of industries told the Supreme Court they have an important stake in the outcome because of the need for a “well-run, predictable patent system that fairly rewards investments in innovation.”
  • The brief argues that the Federal Circuit’s decision on statutory patent term guarantees for Patent Office delays has caused upheaval in the patent system, potentially costing biopharma and tech innovators billions in lost patent term. The brief warns that there is an urgency for the Supreme Court to act, stating, “The ruling impacts the investments (many of which will be years in the making) that companies like the amici are making now.”

The Orrick team on the amicus effort is led by partners Mel Bostwick, Clem Roberts, and Irena Royzman, and associate Jingyuan Luo.